Nieuwenhuis EJ, Castelijns JA, Pijpers R, van den Brekel MW, Brakenhoff RH, van der Waal I, Snow GB, Leemans CR. Wait-and-see policy for the N0 neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: is there a role for idententificatio of the sentinel node? Head Neck 2002 Mar;24(3):282-9.
Castelijns JA, van den Brekel MW. Imaging of lymphadenopathy in the neck. Eur Radiol 2002 Apr; 12(4):727-38.
de Bree R, van den Berg FG, van Schaik C, Beerens AJ, Manoliu RA, Castelijns JA, Snow GB, Leemans CR. Assessment of patency of the internal jugular vein following neck dissection and microvascular flap reconstruction by power Doppler ultrasound. J Laryngol Otol 2002 Aug;116(8):622-6.
Castelijns JA, Leemans CR. Detection of residual disease of lymph node metastasis in the neck, which is treated by (chemo)radiation, AJNR Am J Neuroradiol 2002 Nov-Dec;23(10):1618-9.
Eline JC Nieuwenhuis, Lies H Jaspars, Jonas A Castelijns, Branco Bakker, Richard GA Wishaupt, Fedor Denkers, C René Leemans, Gordon B Snow, Ruud H Brakenhoff. Quantitative Molecular Detection of Minimal Residual Head and Neck Cancer in Lymph Node Aspirates. Clin Cancer Res. 2003 Feb;9(2):755-61.
Nieuwenhuis EJ, Jaspers LH, Castelijns JA, Bakker B, Wishaupt RG, Denkers F, Leemans CR, Snow GB, Brakenhoff RH. Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates. Clin Cancer Res. 2003 Feb;9(2):755-61.
Nieuwenhuis EJ, Pijpers R, Castelijns JA, Snow GB. Lymphoscintigraphic details of sentinel lymph node detection in 82 patients with squamous cell carcinoma of the oral cavity and oropharynx. Nucl Med Commun. 2003 Jun;24(6):651-6.
De Bree R, Deganello A, Smeele LE, Castelijns JA, Leemans, CR. Veranderingen in de TNM-classificatie van het hoofd-halscarcinoom. Ned Tijdschr KNO-Heelk 2003, Apr., 9(2), 73-78.
Brouwer J, Bodar EJ, De Bree R, Langendijk JA, Castelijns JA, Hoekstra OS, Leemans CR. Detecting recurrent laryngeal carcinoma after radiotherapy: Room for improvement. Eur Arch Otorhinolaryngol, 2003;19.
Brouwer J, De Bree R, Comans EFI, Castelijns JA, Hoekstra OS, Leemans CR. Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior? Eur Arch Otorhinolaryngol, Eur Arch Otorhinolaryngol. 2003 Dec 17.
Schrijvers D, Van Herpen C, Kerger J, Joosens E, Van Laer C, Awada A, Van den Weyngaert D, Nguyen H, Bragas B, Castelijns J, Kaanders J. De Mulder P, Vermorken JB. Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I/II feasibility study. Annals of Oncology, 2004 Apr;15(4):638-45.
Ljumanovic R, Langendijk JA, Schenk B, Van Wattingen M, Knol DL, Leemans CR, Castelijns JA.
Supraglottic carcinoma treated with curative radiation therapy: identification of prognostic groups with MR imaging. Radiology. 2004 Aug;232(2):440-8.
Mukherji SK, Schmalfuss IM, Castelijns J, Mancuso AA.
Clinical applications of tumor volume measurements for predicting outcome in patients with squamous cell carcinoma of the upper aerodigestive tract.
AJNR Am J Neuroradiol. 2004 Sep;25(8):1425-32. Review.
Brouwer J, de Bree R, Comans EF, Castelijns JA, Hoekstra OS, Leemans CR.
Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?
Eur Arch Otorhinolaryngol. 2004 Oct;261(9):479-83. Epub 2003 Dec 17.
Nieuwenhuis EJ, van der Waal I, Leemans CR, Kummer A, Pijpers R, Castelijns JA, Brakenhoff RH, Snow GB. Histopathologic validation of the sentinel node concept in oral and oropharyngeal squamous cell carcinoma. Head Neck. 2005 Feb;27(2):150-8.
de Graaf P, Barkhof F, Moll AC, Imhof SM, Knol DL, van der Valk P, Castelijns JA.
Retinoblastoma: MR imaging parameters in detection of tumor extent.
Radiology. 2005 Apr;235(1):197-207.
van den Brekel MWM, Castelijns JA. Imaging of Neck Node Metastases: Clinical perspective and Ultrasound. Cancer Imaging. 2005 Volume 5, Special Issue A; S41-S49
Brouwer J, de Bree R, Hoekstra OS, Golding RP, Langendijk JA, Castelijns JA, Leemans CR. Screening for distant metastases in patients with head and neck cancer: is chest computed tomography sufficient? Laryngoscope. 2005 Oct;115(10):1813-7.
Brouwer J, Bree R, Hoekstra OS, Langendijk JA, Castelijns JA, Leemans CR.
Screening for distant metastases in patients with head and neck cancer: what is the current clinical practice? Clin Otolaryngol. 2005 Oct;30(5):438-43.
Brouwer J, Senft A, de Bree R, Comans EF, Golding RP, Castelijns JA, Hoekstra OS, Leemans CR. Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET? Oral Oncol. 2006 Mar;42(3):275-80. Epub 2005 Nov 2.
de Bree R, Leemans CR, Castelijns JA, Hoekstra OS.
The detection rate for lung metastases or synchronous lung primary tumors in patients with newly diagnosed head and neck squamous cell carcinoma.
Head Neck. 2006 Mar;28(3):280-1; author reply 281-2.
de Graaf P, Castelijns JA, Moll AC, Imhof SM, Schouten-van Meeteren AY.
Atrophic chorioretinal scar and focal scleral bowing following thermochemotherapy with a diode laser for retinoblastoma. Ophthalmic Genet. 2006 Mar;27(1):33-5.
Borjesson PK, Jauw YW, Boellaard R, de Bree R, Comans EF, Roos JC, Castelijns JA, Vosjan MJ, Kummer JA, Leemans CR, Lammertsma AA, van Dongen GA.
Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2133-40.
de Graaf P, Moll AC, Imhof SM, van der Valk P, Castelijns JA.
Retinoblastoma and optic nerve enhancement on MRI: not always extraocular tumour extension. Br J Ophthalmol. 2006 Jun;90(6):800-1.
Ljumanovic R, Langendijk JA, Hoekstra OS, Rene Leemans C, Castelijns JA.
Distant metastases in head and neck carcinoma: Identification of prognostic groups with MR imaging. Eur J Radiol. 2006 Jul 7.
de Graaf P, Knol DL, Moll AC, Imhof SM, Schouten-van Meeteren AY, Castelijns JA.
Eye Size in Retinoblastoma: MR Imaging Measurements in Normal and Affected Eyes.
Radiology. 2007 Jul;244(1):273-80.
Ljumanovic R, Langendijk JA, van Wattingen M, Schenk B, Knol DL, Leemans CR, Castelijns JA.
MR Imaging Predictors of Local Control of Glottic Squamous Cell Carcinoma Treated with Radiation Alone. Radiology. 2007 Jul;244(1):205-212.
Ljumanovic R, Pouwels PJ, Langendijk JA, Knol DL, van der Valk P, Leemans CR, Castelijns JA. Has the degree of contrast enhancement with MR imaging in laryngeal carcinoma added value to anatomic parameters regarding prediction of response to radiation therapy? AJNR Am J Neuroradiol. 2007 Sep;28(8):1540-6
de Graaf P, van der Valk P, Moll AC, Imhof SM, Schouten-van Meeteren AY, Castelijns JA. Retinal dysplasia mimicking intraocular tumor: MR imaging findings with histopathologic correlation. AJNR Am J Neuroradiol. 2007 Oct;28(9):1731-3.
Schouten-van Meeteren AY, van der Valk P, Moll AC, Imhof SM, de Graaf P, Siregar NCh, Darmiati S, Asih D, Gatot D, Tehuteru E, Simangunsong LB, Sitorus RS.International retinoblastoma staging system helps to bridge the gap. Pediatr Blood Cancer. 2008 Mar;50(3):733.
Brouwer J, de Bree R, Comans EF, Akarriou M, Langendijk JA, Castelijns JA, Hoekstra OS, René Leemans C. Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method. Radiother Oncol. 2008 Mar 6.
Dicker GJ, van Spronsen PH, van Ginkel FC, Castelijns JA, van Schijndel RA, Boom HP, Tuinzing DB. Adaptation of lateral pterygoid and anterior digastric muscles after surgical mandibular advancement procedures in different vertical craniofacial types: A magnetic resonance imaging study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Feb 23.
Brouwer J, Hooft L, Hoekstra OS, Riphagen II, Castelijns JA, de Bree R, Leemans CR.Systematic review: Accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy. Head Neck. 2008 Jan 22
Boom HP, van Spronsen PH, van Ginkel FC, van Schijndel RA, Castelijns JA, Tuinzing DB. A comparison of human jaw muscle cross-sectional area and volume in long- and short-face subjects, using MRI. Arch Oral Biol. 2008 Mar;53(3):273-81.
Meijer OW, Weijmans EJ, Knol DL, Slotman BJ, Barkhof F, Vandertop WP, Castelijns JA.
Tumor-volume changes after radiosurgery for vestibular schwannoma: implications for follow-up MR imaging protocol. AJNR Am J Neuroradiol. 2008 May;29(5):906-10. Epub 2008 Feb 22
Ljumanovic R, Langendijk JA, Hoekstra OS, Knol DL, Leemans CR, Castelijns JA.
Pre- and post-radiotherapy MRI results as a predictive model for response in laryngeal carcinoma.
Eur Radiol. 2008 Oct;18(10):2231-40. Epub 2008 May 20.
Castelijns JA, Leemans CR. Closing the uncertainty gap in the diagnosis of parotid tumors.
AJNR Am J Neuroradiol. 2009 Mar;30(3):442-3. Epub 2008 Dec 12.
De Bree R, van der Putten L, Brouwer J, Castelijns JA, Hoekstra OS, Leemans CR. Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging. Oral Oncol, 2009 Apr-May;45(4-5):386-93. Epub 2008 Dec 17
De Bree R, van der Waal I, Doornaert P, Werner JA, Castelijns JA, Leemans CR,
Indications and extent of elective neck dissection in patients with early stage oral and oropharyngeal carcinoma: nationwide survey in The Netherlands. J Laryngol Otol, 2009 Aug;123(8):889-98.
De Bree R, Hoekstra OS, Castelijns JA, Leemans CR, Effectiveness of X-ray and computed tomography screening for assessing pulmonary involvement in patients with head and neck squamous cell carcinoma, J Laryngol Otol. 2009 Sep;123(9):1061-2; author reply 1062. Epub 2009 May 20.
De Bree R, Castelijns JA, Hoekstra OS, Leemans CR
Advances in imaging in the work-up of head and neck cancer patients.
Oral Oncol. 2009 Nov;45(11):930-5. Epub 2009 Aug 18
Börjesson PK, Jauw YW, de Bree R, Roos JC, Castelijns JA, Leemans CR, van Dongen GA, Boellaard R.Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients, J Nucl Med. 2009 Nov;50(11):1828-36. Epub 2009 Oct 16
Mukherji SK, Castelijns JA, CT Perfusion of Head and Neck Cancer: Why We Should Care versus Why Should We Care! AJNR Am J Neuroradiol. 2009 Nov 19.
Rodjan F, de Graaf P, Moll AC, Imhof SM, Verbeke JI, Sanchez E, Castelijns JA.
Brain Abnormalities on MR Imaging in Patients with Retinoblastoma.
AJNR Am J Neuroradiol. 2010 Apr 22.
de Graaf P, van der Valk P, Moll AC, Imhof SM, Schouten-van Meeteren AY, Knol DL, Castelijns JA. Contrast-enhancement of the anterior eye segment in patients with retinoblastoma: correlation between clinical, MR imaging, and histopathologic findings. AJNR Am J Neuroradiol. 2010 Feb;31(2):237-45. Epub 2009 Oct 15.